After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

FDA Commissioner Marty Makary says the agency wants to remove barriers for patients suffering from rare genetic conditions.

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...

Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now.

The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...

Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.

We’ve seen gene-editing in works of fiction make wonders for humans and the environment, from creating “healing factors” in humans, to transforming agriculture for greater sustainability. Genetic ...